These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14566258)

  • 21. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting.
    Davis TW; Zweifel BS; O'Neal JM; Heuvelman DM; Abegg AL; Hendrich TO; Masferrer JL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):929-34. PubMed ID: 14711936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination.
    Evans DM; Sloan Stakleff KD
    Clin Exp Metastasis; 2004; 21(4):339-46. PubMed ID: 15554390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
    Park W; Oh YT; Han JH; Pyo H
    J Exp Clin Cancer Res; 2008 Nov; 27(1):66. PubMed ID: 19000324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
    Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
    Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase inhibitors modulate NK activities that control metastatic disease.
    Kundu N; Walser TC; Ma X; Fulton AM
    Cancer Immunol Immunother; 2005 Oct; 54(10):981-7. PubMed ID: 15891886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.
    Zhu J; Huang JW; Tseng PH; Yang YT; Fowble J; Shiau CW; Shaw YJ; Kulp SK; Chen CS
    Cancer Res; 2004 Jun; 64(12):4309-18. PubMed ID: 15205346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11.
    Trifan OC; Durham WF; Salazar VS; Horton J; Levine BD; Zweifel BS; Davis TW; Masferrer JL
    Cancer Res; 2002 Oct; 62(20):5778-84. PubMed ID: 12384538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
    Levitt RJ; Pollak M
    Cancer Res; 2002 Dec; 62(24):7372-6. PubMed ID: 12499282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.
    Udd L; Katajisto P; Rossi DJ; Lepistö A; Lahesmaa AM; Ylikorkala A; Järvinen HJ; Ristimäki AP; Mäkelä TP
    Gastroenterology; 2004 Oct; 127(4):1030-7. PubMed ID: 15480979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J
    Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
    Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
    World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats.
    Holzhausen M; Rossa Júnior C; Marcantonio Júnior E; Nassar PO; Spolidório DM; Spolidório LC
    J Periodontol; 2002 Sep; 73(9):1030-6. PubMed ID: 12296588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro.
    Slattery MM; Friel AM; Healy DG; Morrison JJ
    Obstet Gynecol; 2001 Oct; 98(4):563-9. PubMed ID: 11576568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.